Editor of Free Expression Matthew Hennessey welcomes readers to the newsletter. The world is endlessly fascinating, and getting more so in this era of rapid change in technology, cultural mores, and ...

A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

An Oskaloosa, Kansas, parent is suing her local school district, alleging it failed to protect her son from repeated sexual assault by another student. The lawsuit claims the student was threatened ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

Seventeen individuals involved in a COVID-19 pandemic unemployment benefit scheme have learned their punishment with the final defendant sentenced earlier this month in a U.S. District Court in ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

After receiving his degree in Journalism & Media Communications from CSU in 2019, Erik began building his career in online media, and found his dream job when he joined Game Rant as a staff writer.

TOKYO, July 23 (Reuters) - Japan will import more rice from the United States but within the existing tariff-free quota, Prime Minister Shigeru Ishiba said on Wednesday, stressing Tokyo's success in ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...